Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Sleep Disorders Excellence Forum

Sleep Disorders
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Kristen P. Perrett, PhD, and Gillian M. Nixon, PhD.
Q&As
Prioritizing Practical Treatment Options for Pediatric Sleep-Disordered Breathing
03/13/2023
Specialty treatment is often called upon for pediatric sleep-disordered breathing, but there may be a more accessible option available through primary care. Neurology Learning Network spoke with Kristen P. Perrett, associate professor,...
Specialty treatment is often called upon for pediatric sleep-disordered breathing, but there may be a more accessible option available through primary care. Neurology Learning Network spoke with Kristen P. Perrett, associate professor,...
Specialty treatment is often...
03/13/2023
Neurology
Kristen P. Perrett, PhD, and Gillian M. Nixon, PhD.
Q&As
Intranasal Spray an Effective First-Line Treatment for Pediatric Sleep-Disordered Breathing
02/27/2023
While the recommended treatment for pediatric sleep-disordered breathing is often a tonsillectomy, could there be a quicker, easier, and less painful first-line treatment administered in a primary care setting? Find out in this expert Q&A.
While the recommended treatment for pediatric sleep-disordered breathing is often a tonsillectomy, could there be a quicker, easier, and less painful first-line treatment administered in a primary care setting? Find out in this expert Q&A.
While the recommended treatment...
02/27/2023
Neurology
Q&A
Q&As
Poor Sleep Linked With Future Cognitive Decline, Clinicians Should Target Intervention
02/07/2023
Dr Behrens provides much-needed insight as clinicians treat patients presenting symptoms of sleep disorders who may be at risk for future decline.
Dr Behrens provides much-needed insight as clinicians treat patients presenting symptoms of sleep disorders who may be at risk for future decline.
Dr Behrens provides much-needed...
02/07/2023
Neurology
Which therapy type is best for insomnia treatment?
Expert Insights Quiz
Which therapy type is best for insomnia treatment?
01/26/2023
Pop quiz!
Pop quiz!
Pop quiz!
01/26/2023
Neurology
Stephen SIlberstein, MD, and Karl Doghramji, MD.
Podcasts
The Connection Between Sleep Disturbances and the Glymphatic System
01/20/2023
Listen to a discussion on the importance of sleep in the production of body homeostasis and the glymphatic system's ability to drain buildup of toxins in the brain.
Listen to a discussion on the importance of sleep in the production of body homeostasis and the glymphatic system's ability to drain buildup of toxins in the brain.
Listen to a discussion on the...
01/20/2023
Neurology
Conference Coverage
Cognitive Behavioral Therapy, Telehealth Among Recent Advances in Treatment of Chronic Insomnia
07/15/2021
In this video, Michael Vitiello, PhD, professor of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, discusses his recent virtual presentation at Neurology Week, titled “Recent Research Advances in Treatment...
In this video, Michael Vitiello, PhD, professor of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, discusses his recent virtual presentation at Neurology Week, titled “Recent Research Advances in Treatment...
In this video, Michael Vitiello,...
07/15/2021
Neurology
Videos
Carlos H. Schenck, MD, Highlights Developments in REM Sleep Behavior Disorder
06/18/2021
In this video, Carlos H. Schenck, MD, Professor of Psychiatry, University of Minnesota Medical School; Senior Staff Physician, Minnesota Regional Sleep Disorders Center, Hennepin County Medical Center, Minneapolis, Minnesota, discusses his...
In this video, Carlos H. Schenck, MD, Professor of Psychiatry, University of Minnesota Medical School; Senior Staff Physician, Minnesota Regional Sleep Disorders Center, Hennepin County Medical Center, Minneapolis, Minnesota, discusses his...
In this video, Carlos H....
06/18/2021
Neurology
Systematic Review Cautions Promoting White Noise Machines as a Viable Sleep Aid
Q&As
Systematic Review Cautions Promoting White Noise Machines as a Viable Sleep Aid
04/08/2021
A new systematic review of 38 studies that assessed the impact of white noise machines on sleep indicates that more research is needed to assess the benefits and harms of these machines. Study author Mathias Basner, MD, PhD, answered our...
A new systematic review of 38 studies that assessed the impact of white noise machines on sleep indicates that more research is needed to assess the benefits and harms of these machines. Study author Mathias Basner, MD, PhD, answered our...
A new systematic review of 38...
04/08/2021
Neurology
The Neurologist Is In, Episode 3: Fostering Wellness in Neurology With Dr Jennifer Rose V. Molano and Dr Jennifer Bickel
Podcasts
The Neurologist Is In, Episode 3: Fostering Wellness in Neurology With Dr Jennifer Rose V. Molano and Dr Jennifer Bickel
02/05/2021
In episode 3, Rachel Marie E. Salas, MD, interviews Jennifer Rose V. Molano, MD, and Jennifer Bickel, MD, about their career journeys with wellness in their respective fields of sleep medicine and headache medicine; tips for gauging your...
In episode 3, Rachel Marie E. Salas, MD, interviews Jennifer Rose V. Molano, MD, and Jennifer Bickel, MD, about their career journeys with wellness in their respective fields of sleep medicine and headache medicine; tips for gauging your...
In episode 3, Rachel Marie E....
02/05/2021
Neurology
COVID-19: Could Obstructive Sleep Apnea Independently Raise Morbidity, Mortality Risk?
Q&As
COVID-19: Could Obstructive Sleep Apnea Independently Raise Morbidity, Mortality Risk?
02/03/2021
The ongoing COVID-19 pandemic has significantly impacted the diagnosis, management, and treatment of obstructive sleep apnea—a condition that may independently increase risk for COVID-19-related morbidity and mortality among some...
The ongoing COVID-19 pandemic has significantly impacted the diagnosis, management, and treatment of obstructive sleep apnea—a condition that may independently increase risk for COVID-19-related morbidity and mortality among some...
The ongoing COVID-19 pandemic...
02/03/2021
Neurology

Advertisement

Advertisement

News

Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement